Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Pathology and Oncology Research – incl. option to publish open access (Editorial Board)

Pathology & Oncology Research

Pathology & Oncology Research

Official Journal of the Arányi Lajos Foundation

Editors-in-Chief: L. Kopper; J. Tímár

ISSN: 1219-4956 (print version)
ISSN: 1532-2807 (electronic version)

Journal no. 12253

Editors-in-Chief

Prof. Dr. László KOPPER
1st Department of Pathology and Experimental Cancer Research
Semmelweis University of Medicine
Üllôi út 26.
Budapest, H-1085
Hungary 

Prof. Dr. József TÍMÁR
Semmelweis University
2nd Department of Pathology
Ráth Gy. u. 7–9.
Budapest, H-1122
Hungary

Managing Editor

Dr. Zsolt OROSZ
Department of Human and Experimental Pathology
National Institute of Oncology
Ráth Gy. u. 7–9.
Budapest, H-1122
Hungary

Editorial Consultants

Dr. Ian A CREE
Translational Oncology Research Centre
Department of Histopathology
Michael Darmady Laboratory
Queen Alexandra Hospital, Cosham
Portsmouth PO6 3LY
United Kingdom 

Dr. Mary JC HENDRIX
President and Scientific Director
Children’s Memorial Institute for Education and Research
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
2300 Children’s Plaza, Box 222
Chicago, Illinois 60614-3394
USA

Dr. Andrea LADÁNYI
Department of Tumor Progression
National Institute of Oncology
Ráth Gy. u. 7–9.
Budapest, H-1122
Hungary

Editorial Board

Dr. Adriana ALBINI, IRCCS Multimedica, Milano, Italy; Dr. Zsolt ARGÉNYI, University of Washington, School of Medicine, Anatomic Pathology, Seattle, Washington, USA; Prof. Dr. Miklós BODÓ, Sejtdiagnosztika Kft., Budapest, Hungary; Dr. Fred BOSMAN, University Institute of Pathology, Lausanne, Switzerland; Dr. Gábor CSERNI, Bács-Kiskun County Teaching Hospital, Pathologiai Osztály, Kecskemét, Hungary; Dr. Helmut DENK, Institute für Patologische Anatomie, der Karl Franzens Universitat, Graz, Austria; Prof. Dr. Sándor ECKHARDT, National Institute of Oncology, Budapest, Hungary; Dr. Dusan FERLUGA, Institute of Pathology, University of Ljubjana, Medical Faculty, Ljubjana, Slovenia; Øysten FODSTAD, Department of Tumor Biology, The Norwegian Radium Hospital, Oslo, Norway; Dr. Meenhard HERLYN, The Wistar Institute of Anatomy and Biology, Philadelphia PA, USA; Dr. Kenneth V. HONN, Cancer Biology Div., Dept. of Radiation Oncology, Wayne State University, Detroit, MI, USA; Dr. Janet A HOUGHTON, Department of Cancer Biology/NB40, Lerner Research Institute, The Cleveland Clinic Foundation, OH, USA; Dr. Renato V. IOZZO, Department of Pathology and Cell Biology, Thomas Jefferson University Philadelphia PA, USA; Dr. Peter V. ISAACSON, Department of Histopathology, University College London Medical School, London, UK; Prof. Dr. András JENEY, Ist Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Prof. Dr. Anna KÁDÁR, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary; Dr. Andras KHOOR, Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA; Dr. George KLEIN, Microbiology and Tumor Biology Center, Karoliska Institute, Stockholm, Sweden; Prof. Dr. Ilona KOVALSZKY, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Dr. Tibor KRENÁCS, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Dr. Thomas KRAUSZ, The University of Chicago, Chicago, Illinois, USA; Prof.Dr. Janina KULKA, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary; Dr. Takeshi KURATA, Real-World Based Interaction Group, Information Technology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan; Dr. Tamara LAH, National Institute of Biology, Ljubjana, Slovenia; Prof. Dr. Károly LAPIS, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Prof. Dr. András MATOLCSY, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Dr. Michael NISHIMURA, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA; Dr. Yukio NISHIMURA, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; Dr. Lajos PUSZTAI, The University of texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston TX, USA; Dr. Giuliano RAMADORI, Georg August University, Department of Gastroenterology and Endocrinology, Göttingen, Germany; Dr. Avraham RAZ, Metastasis Research Program, Michigan Cancer Foundation, Detroit, MI, USA; Dr. Zoltán SÁPI, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Prof. Dr. Zsuzsa SCHAFF, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary; Prof. Dr. Péter SÓTONYI, Department of Forensic Medicine, Semmelweis University, Budapest, Hungary; Prof. Dr. Béla SZENDE, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Dr. Snorri S. THORGEIRSSON, Laboratory of Experimental Carcinogenesis, Center for Cancer Reseach, National Cancer Institute, Bethesda, MD, USA; Dr. Jan G. van den TWEEL, Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

 

Articles

For authors and editors


  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 1.806
  • Aims and Scope

    Aims and Scope

    Close

    Pathology & Oncology Research (POR) is an interdisciplinary Journal at the interface of pathology and oncology including the preclinical and translational research, diagnostics and therapy. Furthermore, POR is an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments on the selected biomedical fields bridging the gap between basic research and clinical medicine. It is a special aim for POR to promote pathological and oncological publishing activity of colleagues in the Central and East European region. The journal will be of interest to pathologists, and a broad range of experimental and clinical oncologists, and related experts. POR is supported by an acknowledged international advisory board and the Arányi Fundation for modern pathology.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for authors

    Pathology & Oncology Research

    Close

  • Author Academy: Training for Authors

Alerts for this journal

 

Get the table of contents of every new issue published in Pathology & Oncology Research.